Aly-khanLalaniMD

Other MD/DO • Boston, MA

Physician

Join to view full profile

Are you Dr. Lalani?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

Connect with colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

Claim this profile

Not you? Find your profile

Office
450 Brookline Ave # DANA1230
Boston, MA 02215
Phone+1 617-632-5456
Is this information wrong?

Publications & Presentations

PubMed

56 citations
Effect of Antibiotic Use on Outcomes with Systemic Therapies in Metastatic Renal Cell Carcinoma
Aly-Khan A. Lalani, Wanling Xie, David A. Braun, Marina D. Kaymakcalan, Dominick Bossé, John A. Steinharter, Dylan J. Martini, Ronit Simantov, Xun Lin, Xiao X. Wei, Br...> ;European Urology Oncology. 2020 Jun 1
8 citations
Response of Primary Renal Cell Carcinoma to Systemic Therapy
Dominick Bossé, Xun Lin, Ronit Simantov, Aly-Khan A. Lalani, Ithaar Derweesh, Steven L. Chang, Toni K. Choueiri, Rana R. McKay> ;European Urology. 2019 Dec 1
134 citations
Metabolomic adaptations and correlates of survival to immune checkpoint blockade
Haoxin Li, Kevin Bullock, Carino Gurjao, David A. Braun, Sachet A. Shukla, Dominick Bossé, Aly-Khan A. Lalani, Shuba Gopal, Chelsea Jin, Christine Horak, Megan Wind-Ro...> ;Nature Communications. 2019 Sep 25
23 citations
Everolimus and pazopanib (E/P) benefit genomically selected patients with metastatic urothelial carcinoma
Joaquim Bellmunt, Aly-Khan A. Lalani, Sussana Jacobus, Stephanie A. Wankowicz, Laura Polacek, David Y. Takeda, Lauren C. Harshman, Nikhil Wagle, Irene Moreno, Kevin Lu...> ;British Journal of Cancer. 2018 Sep 17
83 citations
The Clinical Activity of PD-1/PD-L1 Inhibitors in Metastatic Non-Clear Cell Renal Cell Carcinoma.
Rana R. McKay, Dominick Bossé, Wanling Xie, Stephanie A. Wankowicz, Abdallah Flaifel, Raphael Brandao, Aly-Khan A. Lalani, Dylan J. Martini, Xiao X. Wei, David A. Brau...> ;Cancer Immunology Research. 2018 May 10
26 citations
Apatorsen plus docetaxel versus docetaxel alone in platinum-resistant metastatic urothelial carcinoma (Borealis-2)
Jonathan E. Rosenberg, Noah M. Hahn, Meredith M. Regan, Lillian Werner, Ajjai Alva, Saby George, Joel Picus, Robert S. Alter, Arjun Vasant Balar, Jean H. Hoffman-Censi...> ;British Journal of Cancer. 2018 May 1
28 citations
Targeted genomic landscape of metastases compared to primary tumours in clear cell metastatic renal cell carcinoma.
Guillermo de Velasco, Stephanie A. Wankowicz, Russell Madison, Siraj M. Ali, Craig Norton, Audrey Duquette, Jeffrey S. Ross, Dominick Bossé, Aly-Khan A. Lalani, Vincen...> ;British Journal of Cancer. 2018 Apr 20
187 citations
Change in neutrophil-to-lymphocyte ratio (NLR) in response to immune checkpoint blockade for metastatic renal cell carcinoma
Aly-Khan A. Lalani, Wanling Xie, Dylan J. Martini, John A. Steinharter, Craig Norton, Katherine M. Krajewski, Audrey Duquette, Dominick Bossé, Joaquim Bellmunt, Elieze...> ;Journal for Immunotherapy of Cancer. 2018 Jan 22
2 citations
JAVELIN: avelumab another spear to fight urothelial carcinoma
Aly-Khan A. Lalani, Bradley Alexander McGregor, Guru Sonpavde, Toni K. Choueiri> ;The Lancet. Oncology. 2018 Jan 1
52 citations
Durable Clinical Benefit in Metastatic Renal Cell Carcinoma Patients Who Discontinue PD-1/PD-L1 Therapy for Immune-Related Adverse Events.
Dylan J. Martini, Lana Hamieh, Rana R. McKay, Lauren C. Harshman, Raphael Brandao, Craig Norton, John A. Steinharter, Katherine M. Krajewski, Xin Gao, Fabio A.B. Schut...> ;Cancer Immunology Research. 2018 Jan 1
3 citations
Upper Tract Urothelial Carcinomas: Prognostic Factors and Outcomes in Patients With Non-Lymph Node Distant Metastasis.
Elena Sevillano, Lillian Werner, Dominick Bossé, Aly-Khan A. Lalani, Stephanie A. Wankowicz, Guillermo Velasco, Matthew S. Farina, Kevin Lundgren, Toni K. Choueiri, Ar...> ;Clinical Genitourinary Cancer. 2017 Dec 1
15 citations
Differential expression of c-Met between primary and metastatic sites in clear-cell renal cell carcinoma and its association with PD-L1 expression
Aly-Khan A. Lalani, Kathryn P. Gray, Laurence Albiges, Marcella Callea, Jean-Christophe Pignon, Soumitro Pal, Mamta Gupta, Rupal S. Bhatt, David F. McDermott, Michael ...> ;Oncotarget. 2017 Oct 23
16 citations
Immunotherapy in the Elderly
Aly-Khan A. Lalani, Dominick Bossé, Bradley Alexander McGregor, Toni K. Choueiri> ;European Urology Focus. 2017 Oct 1
36 citations
Response to single agent PD-1 inhibitor after progression on previous PD-1/PD-L1 inhibitors: a case series.
Dylan J. Martini, Aly-Khan A. Lalani, Dominick Bossé, John A. Steinharter, Lauren C. Harshman, F. Stephen Hodi, Patrick A. Ott, Toni K. Choueiri> ;Journal for Immunotherapy of Cancer. 2017 Aug 15
43 citations
Pan-urologic cancer genomic subtypes that transcend tissue of origin
Fengju Chen, Yiqun Zhang, Dominick Bossé, Aly-Khan A. Lalani, A. Ari Hakimi, James J. Hsieh, Toni K. Choueiri, Don L. Gibbons, Michael Ittmann, Chad J. Creighton> ;Nature Communications. 2017 Aug 4
33 citations
Proton Pump Inhibitors and Survival Outcomes in Patients With Metastatic Renal Cell Carcinoma.
Aly-Khan A. Lalani, Rana R. McKay, Xun Lin, Ronit Simantov, Marina D. Kaymakcalan, Toni K. Choueiri> ;Clinical Genitourinary Cancer. 2017 May 31
Join now to see all

Press Mentions

Avelumab in Advanced Urothelial Carcinoma: Further Study Needed to Clarify Its RoleFebruary 10th, 2018